Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone as Adjunctive Therapy to HBO in Acute Carbon Monoxide Poisoning
NCT06574048Phase 2Not yet recruiting
- Sponsor
- University of Nebraska
- Start
- Oct 2026
- Primary completion
- Jul 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial in carbon monoxide poisoning comparing Hyperbaric Oxygen Therapy with Dexamethasone with Hyperbaric Oxygen Therapy with Placebo (Saline) (2 arms). Primary endpoint: Montreal Cognitive Assessment at 12 weeks. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
carbon monoxide poisoning
Beyond the preview
Go deeper on NCT06574048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06574048.